Literature DB >> 8795473

Accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery stenosis in patients with myocardial infarction: the impact of extent and severity of left ventricular dysfunction.

A Elhendy1, R T yan Domburg, J R Roelandt, M L Geleijnse, J H Cornel, G M el-Said, P M Fioretti.   

Abstract

OBJECTIVES: To assess the value of dobutamine stress echocardiography (DSE) in the prediction of the extent and location of coronary artery stenosis in symptomatic patients with old myocardial infarction and to study the impact of the severity of resting wall motion abnormalities (WMA) on the diagnostic accuracy of the test. PATIENTS: One hundred and thirty two symptomatic patients with old myocardial infarction.
METHODS: DSE (up to 40 micrograms/kg/min, with atropine up to 1 mg) was performed in all patients. Ischaemia was defined as new or worsened WMA. For each coronary artery, regional wall motion in the corresponding territory was classified as normal, mildly, moderately, or severely impaired according to the wall motion score index. Significant coronary stenosis was defined as > or = 50% diameter stenosis.
RESULTS: A positive DSE for ischaemia occurred in 87 of 111 patients with and three of 21 patients without coronary artery stenosis (sensitivity = 78%; CI 71 to 86, specificity = 86%; CI 79 to 92, accuracy = 80%; CI 73 to 87). The accuracy for the diagnosis of individual coronary stenosis was 69% in the presence of normal wall motion and 74%, 74%, and 61% respectively when there was mild, moderate, and severe WMA in the corresponding territories (P = NS). The sensitivity was higher in presence of mild or moderate WMA (73%) than with normal wall motion (53%) or severe WMA (56%, P < 0.05 in both). In territories subtended by a stenotic artery, the regional wall motion score index was not different with or without ischaemia.
CONCLUSION: DSE had a good overall accuracy for the diagnosis of coronary artery stenosis in symptomatic patients with old myocardial infarction. The presence of resting WMA did not limit DSE as a method of eliciting myocardial ischaemia and diagnosing significant coronary artery stenosis in patients with old myocardial infarctions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8795473      PMCID: PMC484458          DOI: 10.1136/hrt.76.2.123

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  15 in total

1.  Accuracy of dobutamine stress echocardiography in detecting coronary artery disease.

Authors:  P A Marcovitz; W F Armstrong
Journal:  Am J Cardiol       Date:  1992-05-15       Impact factor: 2.778

2.  Echocardiographic detection of coronary artery disease during dobutamine infusion.

Authors:  S G Sawada; D S Segar; T Ryan; S E Brown; A M Dohan; R Williams; N S Fineberg; W F Armstrong; H Feigenbaum
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

3.  T. Duckett Jones Memorial Lecture. The Jones criteria and the challenges of clinimetrics.

Authors:  A R Feinstein
Journal:  Circulation       Date:  1982-07       Impact factor: 29.690

4.  Effect of prior myocardial infarction and extent and location of coronary disease on accuracy of exercise echocardiography.

Authors:  W F Armstrong; J O'Donnell; T Ryan; H Feigenbaum
Journal:  J Am Coll Cardiol       Date:  1987-09       Impact factor: 24.094

5.  The dobutamine stress test with thallium-201 single-photon emission computed tomography and radionuclide angiography: postinfarction study.

Authors:  I Coma-Canella; M V Gómez Martínez; F Rodrigo; J M Castro Beiras
Journal:  J Am Coll Cardiol       Date:  1993-08       Impact factor: 24.094

6.  Usefulness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction.

Authors:  K A Brown; R M Weiss; J P Clements; F J Wackers
Journal:  Am J Cardiol       Date:  1987-07-01       Impact factor: 2.778

Review 7.  "Non-Q wave," alias "nontransmural," myocardial infarction: a specific entity.

Authors:  X André-Fouet; M Pillot; A Leizorovicz; G Finet; C Gayet; H Milon
Journal:  Am Heart J       Date:  1989-04       Impact factor: 4.749

8.  Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease.

Authors:  A Dagianti; M Penco; L Agati; S Sciomer; A Dagianti; S Rosanio; F Fedele
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

9.  Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

Authors: 
Journal:  Am J Cardiol       Date:  1986-07-01       Impact factor: 2.778

10.  Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both?

Authors:  T Marwick; A M D'Hondt; T Baudhuin; B Willemart; W Wijns; J M Detry; J Melin
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

View more
  4 in total

1.  A meta-analytic comparison of echocardiographic stressors.

Authors:  Yoshinori Noguchi; Shizuko Nagata-Kobayashi; James E Stahl; John B Wong
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

2.  Relation between ST segment elevation during dobutamine stress test and myocardial viability after a recent myocardial infarction.

Authors:  A Elhendy; J H Cornel; J R Roelandt; R T van Domburg; M I Geleijnse; P R Nierop; J J Bax; A Sciarra; M M Ibrahim; M el-Refaee; G M el-Said; P M Fioretti
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

3.  Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction.

Authors:  P Lancellotti; T Benoit; P Rigo; L A Pierard
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

4.  Stress echocardiography for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.